Zhaodong Xu

17PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyAutoimmunityMedical mycologyHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 02, 2026
Therapy-related AML with MECOM rearrangement, biallelic TP53 inactivation, and striking nuclear abnormalities.

|Mar 26, 2026
Myelodysplastic CMML-1 mimicking ITP, unmasked by corticosteroids: evolution from clonal monocytosis.

Zhaodong Xu, Monika Hudoba

|Mar 18, 2026
AML, Myelodysplasia-Related With B/Myeloid MPAL Immunophenotype, Normal Karyotype, and SRSF2/ASXL1/FLT3 Co-Mutations.

Zhaodong Xu, Monika Hudoba

|Jan 22, 2026
TP53-mutated AML with salmon-colored globules, a single Auer rod, pseudo-Chédiak-Higashi granules, and micronuclei.

Zhaodong Xu, Nadia Medvedev

|Oct 02, 2025
AML with mutated TP53, therapy-related, with basophilic differentiation, partial CD22, and ring sideroblasts.

Zhaodong Xu, Eric McGinnis

|Mar 20, 2025
Megakaryocyte mitotic figures in de novo AML, myelodysplasia related, with STAG2, SRSF2, and ASXL1 comutations.

Zhaodong Xu, Kristine Roland

Pageof 3

Frequent Collaborators

1 joint publications

Richard Van der Jagt

1 joint publications

Kristine Roland

1 joint publications

Eric McGinnis

1 joint publications

Monika Hudoba